CN1333051A - Medicine for preventing and treating cancer and preparation process thereof - Google Patents
Medicine for preventing and treating cancer and preparation process thereof Download PDFInfo
- Publication number
- CN1333051A CN1333051A CN01114149A CN01114149A CN1333051A CN 1333051 A CN1333051 A CN 1333051A CN 01114149 A CN01114149 A CN 01114149A CN 01114149 A CN01114149 A CN 01114149A CN 1333051 A CN1333051 A CN 1333051A
- Authority
- CN
- China
- Prior art keywords
- herba
- medicine
- cancer
- rhizoma
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The Chinese medicine for preventing and curing cancers is made of 16 Chinese medicinal materials of dried toad, house lizard, mushroom, bushy sophora root, black nightshade etc. Said medicine can convert internal cancer cell into normal cell, can inhibit and kill cancer cell and can raise immunologic function of human body.
Description
The present invention relates to a kind of prevention and the medicine of treatment cancer and the preparation method of this medicine.
Cancer is the disease of serious harm human health, life, the cancer patient has the trend that increases year by year at present, in this case, some have occurred and has improved some health care medicines of body immunity, but these drug effect fruits are bad, even to treating, preventing that cancer from not taking effect.
The purpose of this invention is to provide a kind of short treating period, increase the prevention of immune function of human body, cancer inhibitting and killing cell and the medicine and the preparation method of treatment cancer for a long time.
The object of the present invention is achieved like this: the medicine and the preparation method of a kind of prevention and treatment cancer, and it is characterized in that: it is to be made by following parts by weight proportion raw material:
Bufo siccus 25-30
Gekko Swinhonis 3-5
Mushroom 20-25
Radix Sophorae Tonkinensis 10-15
Herba Solani Nigri 10-15
Herba Solani Lyrati 10-15
Calculus Bovis 5-10
Radix Ginseng 5-10
Rhizoma Atractylodis Macrocephalae 5-10
White dragons and snakes grass 10-15
Herba Selaginellae Doederleinii 10-15
Herba Scutellariae Barbatae 10-15
Herba Sarcandrae 10-15
Herba Galii Teneri 10-15
Herba Artemisiae Anomalae 10-15
Rhizoma Curcumae 10-15
Rhizoma sparganic 10-15
Radix Trichosanthis 10-15
Rhizoma Dioscoreae Bulbiferae 10-15
Pseudobulbus Cremastrae Seu Pleiones 10-15
Nuclear is chosen core 10-15
Semen Strychni 5-10
Mylabris 5-10
Scolopendra 10-15
The present invention is according to the Chinese medicine organic conception; dialectical executing controlled; the reason and the clinical observation of the morbidity of grasping cancer concluded in systematic analysis comprehensively; the morbidity of cancer is because body function is unusual; it is of a specified duration that the corporeal things such as QI and blood phlegm-damp that produce stop day of year, influenced the operation of mechanism of qi, and the cancer poison is attached to be accumulated on these corporeal things gradually; canceration will take place; according to traditional Chinese medical science vital base and primordial QI consolidating, negative and positive are transferred long-pending, lead activating QI off; antitoxin eliminating stagnations etc. are prevented and treated rule; develop the present invention, the present invention can make the normal cell of intravital cancerous cell transformation, energy cancer inhibitting and killing cell; raise immunity, have obviously determine control the cancer protective effect on cancer risk.
Below clinical experiment is summarized as follows:
1, medicament selection
Select medicine of the present invention.
2, case is selected
(1) cancer patient: be diagnosed as the cancer patient through B ultrasonic, CT, X-ray or pathological section etc.(patient who has is through radiotherapy, chemotherapy or operative treatment) wherein male patient is 615 examples, female patient 545 examples, 30 examples below 10 years old, 46 examples in 10-20 year, 454 examples in 20-40 year, 630 examples more than 40 years old.101 examples that 66 examples, gastric cancer are arranged of tumor type hepatocarcinoma, 69 examples of intestinal cancer, pulmonary carcinoma 174 examples, esophageal carcinoma 38 examples, uterus carcinoma 52 examples, lymphatic cancer 30 examples, laryngeal carcinoma 30 examples, leukemia 15 examples, bladder cancer 166 examples, cancer of pancreas 50 examples, renal carcinoma 34 examples, cancer of biliary duct 42 examples, osteosarcoma 18 examples, cerebral glioma 131 examples, mammary cancer 1 34 examples, skin carcinoma 10 examples.
Tumor type and therapeutic effect relationship
Tumor type | Case load | Recovery from illness | Produce effects | Effectively | Invalid | Effective percentage | Inefficiency |
Hepatocarcinoma | 66 | ?26 | ????30 | ????6 | ????4 | ?94% | 6% |
Gastric cancer | 101 | ?51 | ????34 | ????8 | ????8 | ?92% | 8% |
Intestinal cancer | 69 | ?44 | ????10 | ????8 | ????7 | ?89.8% | 10.2% |
Pulmonary carcinoma | 174 | ?105 | ?45 | ????16 | ????8 | ????95.4% | ????4.6% |
Esophageal carcinoma | 38 | ?15 | ?18 | ????3 | ????2 | ????94.7% | ????5.3% |
Uterus carcinoma | 52 | ?28 | ?11 | ????8 | ????5 | ????90.4% | ????9.6% |
Lymphatic cancer | 30 | ?18 | ?5 | ????4 | ????3 | ????90% | ????10% |
Laryngeal carcinoma | 30 | ?17 | ?6 | ????4 | ????3 | ????90% | ????10% |
Leukemia | 15 | ?7 | ?5 | ????2 | ????1 | ????93.3% | ????6.7% |
Bladder cancer | 166 | ?91 | ?40 | ????30 | ????5 | ????97% | ????3% |
Renal carcinoma | 34 | ?14 | ?10 | ????8 | ????2 | ????94.1% | ????5.9% |
Cancer of biliary duct | 42 | ?13 | ?12 | ????12 | ????5 | ????88.1% | ????11.9% |
Osteosarcoma | 18 | ?8 | ?5 | ????4 | ????1 | ????94.4% | ????5.6% |
Breast carcinoma | 134 | ?81 | ?22 | ????18 | ????13 | ????90.3% | ????9.7% |
Skin carcinoma | 10 | ?4 | ?3 | ????2 | ????1 | ????90% | ????10% |
Healing time | |||||||
Tumor type | Case load | Recovery from illness | 15 days | 30 days | 45 days | 60 days | 75 days |
Hepatocarcinoma | ?66 | ??26 | ?0 | ????8 | ????16 | ????1 | ????1 |
Gastric cancer | 101 | ?51 | ?5 | ????28 | ????12 | ????4 | ????2 |
Intestinal cancer | 69 | ?44 | ?4 | ????20 | ????17 | ????2 | ????1 |
Pulmonary carcinoma | 174 | ?105 | ?2 | ????60 | ????31 | ????10 | ????2 |
Esophageal carcinoma | 38 | ?15 | ?0 | ????5 | ????8 | ????1 | ????1 |
Uterus carcinoma | 52 | ?28 | ?3 | ????11 | ????10 | ????3 | ????1 |
Lymphatic cancer | 30 | ?18 | ?0 | ????5 | ????8 | ????3 | ????2 |
Laryngeal carcinoma | 30 | ?17 | ?0 | ????4 | ????7 | ????4 | ????2 |
Leukemia | 15 | ?7 | ?0 | ????2 | ????1 | ????2 | ????2 |
Bladder cancer | 166 | ?91 | ?9 | ????36 | ????15 | ????17 | ???14 |
Renal carcinoma | 34 | ?14 | ?0 | ????2 | ????4 | ????6 | ????2 |
Cancer of biliary duct | 42 | ?13 | ?0 | ????2 | ????4 | ????5 | ????2 |
Osteosarcoma | 18 | ?8 | ?0 | ????1 | ????1 | ????2 | ????4 |
Breast carcinoma | 134 | ?81 | ?10 | ????22 | ????24 | ????12 | ???13 |
Skin carcinoma | 10 | ?4 | ?0 | ????1 | ????1 | ????1 | ????1 |
Therapeutic Method
The patient takes medicine three every day, each 15 grams, and 15 days is a course of treatment.
Curative effect determinate standard:
Recovery from illness: the clinical symptoms complete obiteration of treatment back, check lump complete obiteration or absorption through CT, B ultrasonic or X-ray sheet.
Produce effects: treatment back cardinal symptom disappears substantially, and focus is dwindled over half, observes continuously 3-6 month, no longer the recidivist.
Effectively: make moderate progress through the treatment symptom, focus dwindles into stable, observes 3-6 month no longer recidivist continuously.
Invalid: symptom does not have improvement after treating, or improvement is arranged, deterioration person rapidly again in 1 month.
(2), healthy population
It below is the experimental result of two groups of healthy populations (be respectively and take the present invention and do not take matched group of the present invention)
Take medicine group of the present invention | Matched group | |
Number | ????500 | ????500 |
Dosage | Every day, 15g serviced once after the morning, noon and afternoon | |
Medicine time | Six months | |
The pathogenesis of cancer number | 1 people | 25 people |
Selection crowd's standard: two groups of crowds of areal picked at random, every group 500 people.
The cancer diagnosis standard: lump being arranged and make the pathology slice probing by doctor trained in Western medicine CT, magnetic resonance or the detection of X-ray sheet is the virulent cancer patient of being.
Healthy population gets final product drug withdrawal after generally taking the present invention one course of treatment (promptly 6 months).
Using method: every day 15g, early, middle and lately service once after meal.
Be described in detail technical solution of the present invention below.
Embodiment 1:
The medicine and the preparation method of a kind of prevention and treatment cancer, it is to be made by following parts by weight proportion raw material:
Bufo siccus 25
Gekko Swinhonis 3
Mushroom 20
Radix Sophorae Tonkinensis 10
Herba Solani Nigri 10
Herba Solani Lyrati 10
Calculus Bovis 5
Radix Ginseng 5
The Rhizoma Atractylodis Macrocephalae 5
White dragons and snakes grass 10
Herba Selaginellae Doederleinii 10
Herba Scutellariae Barbatae 10
Herba Sarcandrae 10
Herba Galii Teneri 10
Herba Artemisiae Anomalae 10
Rhizoma Curcumae 10
Rhizoma sparganic 10
Radix Trichosanthis 10
Rhizoma Dioscoreae Bulbiferae 10
Pseudobulbus Cremastrae Seu Pleiones 10
Semen Juglandis 10
Semen Strychni 5
Mylabris 5
Scolopendra 10
Its processing technology is with the broken pulverization of every medicated powder by said ratio.
Embodiment 2:
The medicine and the preparation method of a kind of prevention and treatment cancer, it is to be made by following parts by weight proportion raw material:
Bufo siccus 27
Gekko Swinhonis 4
Mushroom 22
Radix Sophorae Tonkinensis 13
Herba Solani Nigri 13
Herba Solani Lyrati 13
Calculus Bovis 8
Radix Ginseng 8
The Rhizoma Atractylodis Macrocephalae 8
White dragons and snakes grass 13
Herba Selaginellae Doederleinii 13
Herba Scutellariae Barbatae 13
Herba Sarcandrae 13
Herba Galii Teneri 13
Herba Artemisiae Anomalae 13
Rhizoma Curcumae 13
Rhizoma sparganic 13
Radix Trichosanthis 13
Rhizoma Dioscoreae Bulbiferae 13
Pseudobulbus Cremastrae Seu Pleiones 13
Semen Juglandis 13
Semen Strychni 8
Mylabris 8
Scolopendra 13
Its processing technology is with the broken pulverization of every medicated powder by said ratio.
Embodiment 3:
The medicine and the preparation method of a kind of prevention and treatment cancer, it is to be made by following parts by weight proportion raw material:
Bufo siccus 30
Gekko Swinhonis 5
Mushroom 25
Radix Sophorae Tonkinensis 15
Herba Solani Nigri 15
Herba Solani Lyrati 15
Calculus Bovis 10
Radix Ginseng 10
The Rhizoma Atractylodis Macrocephalae 10
White dragons and snakes grass 15
Herba Selaginellae Doederleinii 15
Herba Scutellariae Barbatae 15
Herba Sarcandrae 15
Herba Galii Teneri 15
Herba Artemisiae Anomalae 15
Rhizoma Curcumae 15
Rhizoma sparganic 15
Radix Trichosanthis 15
Rhizoma Dioscoreae Bulbiferae 15
Pseudobulbus Cremastrae Seu Pleiones 15
Semen Juglandis 15
Semen Strychni 10
Mylabris 10
Scolopendra 15
Its processing technology is with the broken pulverization of every medicated powder by said ratio.
Claims (2)
1, the medicine and the preparation method of a kind of prevention and treatment cancer, it is characterized in that: it is to be made by following parts by weight proportion raw material:
Bufo siccus 25-30
Gekko Swinhonis 3-5
Mushroom 20-25
Radix Sophorae Tonkinensis 10-15
Herba Solani Nigri 10-15
Herba Solani Lyrati 10-15
Calculus Bovis 5-10
Radix Ginseng 5-10
Rhizoma Atractylodis Macrocephalae 5-10
White dragons and snakes grass 10-15
Herba Selaginellae Doederleinii 10-15
Herba Scutellariae Barbatae 10-15
Herba Sarcandrae 10-15
Herba Galii Teneri 10-15
Herba Artemisiae Anomalae 10-15
Rhizoma Curcumae 10-15
Rhizoma sparganic 10-15
Radix Trichosanthis 10-15
Rhizoma Dioscoreae Bulbiferae 10-15
Pseudobulbus Cremastrae Seu Pleiones 10-15
Semen Juglandis 10-15
Semen Strychni 5-10
Mylabris 5-10
Scolopendra 10-15
2, a kind of medicine and preparation method of making described prevention of claim 1 and treatment cancer is characterized in that: press said ratio with the broken pulverization of every medicated powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN01114149A CN1130217C (en) | 2001-06-29 | 2001-06-29 | Medicine for preventing and treating cancer and preparation process thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN01114149A CN1130217C (en) | 2001-06-29 | 2001-06-29 | Medicine for preventing and treating cancer and preparation process thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1333051A true CN1333051A (en) | 2002-01-30 |
CN1130217C CN1130217C (en) | 2003-12-10 |
Family
ID=4660822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN01114149A Expired - Fee Related CN1130217C (en) | 2001-06-29 | 2001-06-29 | Medicine for preventing and treating cancer and preparation process thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1130217C (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103341137A (en) * | 2013-06-26 | 2013-10-09 | 芜湖乐锐思信息咨询有限公司 | Formula and preparation method of traditional Chinese medicine for treating cancers |
CN104173920A (en) * | 2014-08-01 | 2014-12-03 | 广西博士海意信息科技有限公司 | Medicine for treating lymphoma |
CN104998082A (en) * | 2015-08-28 | 2015-10-28 | 薛振宇 | Traditional Chinese medicine composition for treating breast tumor |
CN106729407A (en) * | 2016-12-27 | 2017-05-31 | 四川西奈生物科技有限公司 | The Chinese medicine composition for the treatment of cancer |
CN107582984A (en) * | 2017-10-20 | 2018-01-16 | 李绍礼 | A kind of pharmaceutical composition for treating cancer of the esophagus |
-
2001
- 2001-06-29 CN CN01114149A patent/CN1130217C/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103341137A (en) * | 2013-06-26 | 2013-10-09 | 芜湖乐锐思信息咨询有限公司 | Formula and preparation method of traditional Chinese medicine for treating cancers |
CN104173920A (en) * | 2014-08-01 | 2014-12-03 | 广西博士海意信息科技有限公司 | Medicine for treating lymphoma |
CN104998082A (en) * | 2015-08-28 | 2015-10-28 | 薛振宇 | Traditional Chinese medicine composition for treating breast tumor |
CN104998082B (en) * | 2015-08-28 | 2018-08-24 | 薛振宇 | A kind of Chinese medicine composition for treating tumor of breast |
CN106729407A (en) * | 2016-12-27 | 2017-05-31 | 四川西奈生物科技有限公司 | The Chinese medicine composition for the treatment of cancer |
CN107582984A (en) * | 2017-10-20 | 2018-01-16 | 李绍礼 | A kind of pharmaceutical composition for treating cancer of the esophagus |
Also Published As
Publication number | Publication date |
---|---|
CN1130217C (en) | 2003-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1170556C (en) | Chinese medicine for treating neoplasm | |
CN101062361A (en) | Chinese traditional medicine for treating dermatosis and its preparation method | |
CN1768812A (en) | Medicinal composition for removing dampness to relieve itching and its preparation method and uses | |
CN1861163A (en) | Traditional Chinese medicine composition for treating kidney-yang deficiency and deficiency of vital energy and blood, its prepn. process | |
CN1879857A (en) | Medicinal powder for treating mammary gland disease | |
CN1270746C (en) | Medicine for diminishing the inflammation and reducing the pain, subsiding swelling to dissipate indurated mass, dredging meridian to removing stagnation | |
CN1130217C (en) | Medicine for preventing and treating cancer and preparation process thereof | |
CN1857596A (en) | Cancer treating medicine composition and its preparing method | |
CN1864730A (en) | A cancer-treating medicine | |
CN1682896A (en) | Medicine for treating infantile inflammation of upper respiratory tract and its preparing method | |
CN1293896C (en) | Medication for treating primary disease of purpura haemorhagica and preparation method | |
CN1191849C (en) | Chinese medicine for treating breast disease | |
CN1990033A (en) | Drug for treating hypertension, dense blood and arteriosclerosis | |
CN1883662A (en) | Pharmaceutical composition for treating psoriasis | |
CN1254267C (en) | Medicine for treating gastral cavity pain and its preparation method | |
CN1679658A (en) | Chinese medicine preparation for treating AIDS and process thereof | |
CN1157219C (en) | Medicine for treating cancer | |
CN1593493A (en) | Therapy assisting agent and its preparation | |
CN1059333C (en) | Chinese patent drug for various cancers and tumors | |
CN1140071A (en) | Anticancer drug and preparing method thereof | |
CN1304045C (en) | Arthralgia removing pills and their preparation | |
CN1840101A (en) | Chinese medicine with wind-dispelling damp-eliminating, collaterals-dredging, coldness-expelling pain-relieving functions and preparation process thereof | |
CN1060659C (en) | Pill medicine for cancer and preparation method | |
CN1557446A (en) | Compound medicine for treating gout | |
CN1337252A (en) | Chinese medicine for treating chronic bronchitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20031210 Termination date: 20160629 |
|
CF01 | Termination of patent right due to non-payment of annual fee |